journal
MENU ▼
Read by QxMD icon Read
search

Journal of the Advanced Practitioner in Oncology

journal
https://www.readbyqxmd.com/read/29928556/management-of-patients-with-chemotherapy-induced-nausea-and-vomiting
#1
REVIEW
Sally Yowell Barbour
Despite advances in the management of chemotherapy-induced nausea and vomiting (CINV), clinical management remains a challenge and CINV continues to be a side effect that patients fear most. Advanced practitioners can play a major role in evidence-based interventions for prevention and management of these side effects of treatment.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928555/management-of-venous-thromboembolism-for-patients-with-hematologic-malignancies
#2
REVIEW
Rowena N Schwartz
Advanced practitioners are an integral part of the cancer care team. Therefore, it is imperative they are knowledgeable of risk factors associated with venous thromboembolism in the oncology setting, including signs or symptoms and management.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928554/best-practices-in-the-management-of-infectious-complications-for-patients-with-cancer
#3
REVIEW
James S Lewis Ii
As antibiotic resistant bacteria are becoming ubiquitous, managing infection becomes more complex. Optimizing preventive measures, early diagnosis, and management of infection is of the highest priority in cancer care.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928553/new-treatment-strategies-making-an-impact-in-multiple-myeloma
#4
REVIEW
Charise Gleason, Jonathan Kaufman
Even though multiple myeloma remains incurable, mean overall survival has improved dramatically as newer game-changing therapies enter the scene. At the same time, treatment decisions and the management of toxicities related to newer drug regimens are becoming more complex.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928552/nuances-in-the-management-of-aggressive-lymphomas
#5
REVIEW
Paul A Hamlin, Michelle Wisniewski
Treatment for both Hodgkin and Non-Hodgkin lymphoma now includes chemotherapy, targeted therapy, and new immunotherapies. As research continues to shine the light on tumor genetics, clinical variability, and new treatment approaches, advanced practitioners need to translate this information in the management of aggressive lymphomas.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928551/new-treatment-paradigms-defined-for-chronic-lymphocytic-leukemia
#6
REVIEW
Mollie Moran, Jeffrey Jones
Within the past 3 years, the FDA has approved five new treatment options for patients with CLL. While these advances improve patient outcomes and the quality of care, there is a need for advanced practitioners to stay up to date and informed in order to translate these advances into the clinical setting.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928550/diagnosis-and-treatment-of-adenocarcinomas-and-squamous-cell-carcinomas-of-the-lung
#7
REVIEW
Millie Das, Alison Holmes Tisch
Following years in which there were only modest gains in treatment options for non-small cell lung cancer, recognition of targetable mutations and immunogenicity of lung cancer now impact treatment decisions.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928549/advances-in-collaborative-practice-for-patients-with-head-and-neck-cancers
#8
REVIEW
Robert Haddad, Jason Glass
Head and neck cancer care is complex, and there are limited treatment options; over the past decade only one new therapy received FDA approval. However, as in other tumor types, the landscape is changing with the recent emergence of newer targeted therapies and immunotherapies.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928548/what-advanced-practitioners-need-to-know-about-the-diagnosis-and-treatment-of-patients-with-pancreatic-cancer
#9
REVIEW
Joseph M Herman, Amy Hacker-Prietz
Multidisciplinary clinics for pancreatic cancer such as one established at Johns Hopkins offer advantages in the care of patients with pancreatic cancer. Advanced practitioners can play a role in multidisciplinary care, providing symptom management and acute care, and clinical trial enrollment/consent process.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928547/collaborative-management-of-patients-with-estrogen-receptor-positive-breast-cancer
#10
REVIEW
Lee S Schwartzberg, Heather R Greene
Cyclin-dependent kinase (CDK) inhibitors represent a new form of cytotoxic chemotherapy. Advanced practitioners can read this article to find out about the science behind CDK inhibition, when CDKs are indicated, how to monitor for and manage side effects, as well as when and how to dose adjust.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928546/management-of-patients-with-skin-cancers-basal-cell-carcinoma-and-melanoma
#11
REVIEW
Brianna Hoffner, Daniel M Siegel
Novel therapies are changing the treatment paradigm for both melanoma and advanced/metastatic basal cell carcinoma. While immunotherapies are increasing survival benefits in melanoma, they are associated with unique immune-related adverse events.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928545/optimal-collaborative-management-of-patients-with-esophagogastric-cancers
#12
REVIEW
David Ilson, Steve Malangone
The addition of radiation to preoperative chemotherapy and newer therapeutic combinations add to treatment options for these difficult-to-treat cancers.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928544/car-t-cell-therapy-on-the-verge-of-breakthrough-in-many-hematologic-malignancies
#13
REVIEW
Edward Stadtmauer, Patricia A Mangan
There have been promising results from clinical trials on the efficacy of engineering patients' immune cells to treat their cancers. CAR T-cell therapy also has unique toxicities advanced practitioners should be aware of.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928543/advances-in-the-use-of-immunotherapy-in-oncology
#14
REVIEW
Anthony J Olszanski, Laura J Zitella
Innovations in cancer immunotherapy have created new options for patients and avenues for clinicians to practice precision medicine.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29928542/jadpro-live-at-apsho-2016-united-in-practice-united-in-care
#15
EDITORIAL
Pamela Hallquist Viale
No abstract text is available yet for this article.
April 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29900028/nccn-imaging-appropriate-use-criteria-compendium-an-overview
#16
REVIEW
Mistie G Hagaman
No abstract text is available yet for this article.
March 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29900027/osimertinib-a-novel-therapeutic-option-for-overcoming-t790m-mutations-in-non-small-cell-lung-cancer
#17
REVIEW
Shan Li, Eve M Segal
No abstract text is available yet for this article.
March 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29900026/brief-introduction-to-cognitive-behavioral-therapy-for-the-advanced-practitioner-in-oncology
#18
REVIEW
Laura Melton
No abstract text is available yet for this article.
March 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29900025/use-of-diagnostic-tests-in-advanced-non-small-cell-lung-cancer
#19
REVIEW
Beth Eaby-Sandy
INTRODUCTION As the official publication of the Advanced Practitioner Society for Hematology and Oncology (APSHO), JADPRO is pleased to offer Part 1 of an accredited educational activity based on the recently concluded APSHO Regional Lecture Series. Hosted in collaboration with major cancer centers around the country, the APSHO Regional Lecture Series brought case-based didactic presentations and skills workshops to advanced practitioners. In the spirit of JADPRO, three accredited Grand Rounds articles by Beth Eaby-Sandy, MSN, CRNP, OCN® (non-small cell lung cancer) and Sandra E...
March 2017: Journal of the Advanced Practitioner in Oncology
https://www.readbyqxmd.com/read/29900024/current-and-emerging-therapies-for-her2-positive-women-with-metastatic-breast-cancer
#20
REVIEW
Karlyn Porter, Margaret Quinn Rosenzweig
CASE STUDY DE, a 31-year-old premenopausal woman with a nonsignificant medical history, noticed a right breast mass after playing basketball in September 2011. She initially attributed the mass to slight trauma, but after 2 weeks, she realized the mass was increasing in size. Her primary care physician ordered a bilateral screening mammogram and ultrasound. Mammography revealed no evidence of malignancy in the left breast. In the right breast, at the 7 o'clock position, a loose cluster of faint calcifications spanned a 2...
March 2017: Journal of the Advanced Practitioner in Oncology
journal
journal
48476
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"